Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Liyi Pharmaceutical Technology is a Chinese chemical manufacturing company specializing in the research, development, and production of pharmaceutical intermediates and fine chemicals. Based in Zhongxiang, Hubei Province, the company operates a production facility focused on high-quality chemical synthesis to support the global pharmaceutical industry. Their product portfolio includes various intermediates used in the synthesis of active pharmaceutical ingredients (APIs), particularly pyridine derivatives and other heterocyclic compounds. The company emphasizes quality control and technological innovation in its manufacturing processes to serve as a reliable partner in the drug development supply chain. Their services include custom synthesis and large-scale manufacturing for both domestic and international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Liyi Pharmaceutical Technology.